Finding the right balance for nutraceuticals
If nutraceuticals shift from FSSAI to CDSCO, they will also come under price control. While this is good for consumers, industry…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Union Budget 2024 – 25
Budget 2024-25 prioritises R&D, education and business for MSMEs
Industry stakeholders appreciate the efforts made towards increasing employment, skill-building and implementation of various…
Union Budget 2024-25 reflects a forward-looking and inclusive approach
Anil Matai, Director General, OPPI expressed that while positive strides were taken in the Union Budget 2024-25, the pharma sector…
The budget allocation for R&D will be beneficial for the clinical trial industry
Industry stakeholders share their views after the announcement of the Union Budget 2024-25. Increased allocation for R&D,…
Decoding Budget 2024-25: A lacklustre budget for pharma
The Finance Minister announced the Budget for 2024-25 on July 23, during the Monsoon Session of Parliament
Pharma industry experts eye budget boost for innovation and global ambitions
In anticipation of the upcoming Union Budget on July 23 2024, India's $50 billion pharmaceutical industry is seeking a…